State Of Wyoming Celldex Therapeutics, Inc. Transaction History

State Of Wyoming

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$20.5 - $37.33 $12,771 - $23,256	-623 Reduced 74.43%	214 $6,000
Q1 2022 May 13, 2022	SELL	$27.64 - $39.32 $7,490 - $10,655	-271 Reduced 24.46%	837 $29,000
Q4 2021 Feb 11, 2022	BUY	$35.68 - $56.27 $18,517 - $29,204	519 Added 88.12%	1,108 $42,000
Q3 2021 Feb 11, 2022	SELL	$28.95 - $55.99 $12,969 - $25,083	-448 Reduced 43.2%	589 $32,000
Q2 2021 Feb 11, 2022	BUY	$20.71 - $35.37 $14,683 - $25,077	709 Added 216.16%	1,037 $36,000
Q1 2021 Feb 08, 2022	BUY	$16.19 - $29.91 $5,310 - $9,810	328 New	328 $7,000

207

67.3M

1.69M

980K

Ticker CLDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,772,400
Market Cap $1.26B
Description
Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-01...

Get notified when there are updates to the investment portfolio of State Of Wyoming, based on Form 13F filings with the SEC.

Stay updated on State Of Wyoming with notifications on news.